Revenue
2017
2018
2019
2020
2021
2022
2023
2024
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.90T | $4.26T | $4.38T | $2.83T | $2.55T | $2.62T | $2.41T | $2.48T | $2.52T | $2.38T |
| Gross profit | $1.08T | $1.38T | $1.56T | $843.92B | $1.21T | $1.35T | $1.16T | $1.01T | $1.04T | $917.04B |
| Operating income | $373.06B | $767.76B | $912.36B | $259.59B | −$34.26B | $526.05B | $670.60B | $578.63B | $567.79B | $525.49B |
| EBITDAderived | $668.53B | $1.02T | $1.15T | $470.52B | $195.70B | $762.68B | $885.79B | $731.31B | $729.45B | $678.69B |
| Net income | $145.11B | $633.46B | $1.25T | $85.15B | −$50.86B | $296.15B | $361.71B | $349.38B | $384.16B | $251.84B |
| Basic EPSper diluted share | CLP 2.10 | CLP 9.16 | CLP 18.10 | CLP 1.23 | -CLP 0.74 | CLP 4.28 | CLP 5.66 | CLP 7.12 | CLP 7.83 | CLP 5.13 |
| Diluted EPSper diluted share | CLP 2.10 | CLP 9.16 | CLP 18.10 | CLP 1.23 | -CLP 0.74 | CLP 4.28 | CLP 5.66 | CLP 7.12 | CLP 7.83 | CLP 5.13 |